Domain-Specific Monoclonal Antibodies Against Human Rev-erbβ

Fang Chen1,2, Yanqing Li1, Junli Zhao1

  • 1Laboratory of Gene Therapy, Department of Biochemistry, College of Life Sciences, Shaanxi Normal University, 199 South Chang'an Road, Xi'an, 710062, Shaanxi, People's Republic of China.

Insights

Researchers developed five new monoclonal antibodies (MAbs) targeting the Rev-erbβ nuclear receptor. One MAb, 37H8, successfully detected endogenous Rev-erbβ, enabling functional studies of this important transcriptional factor.

Area of Science:

  • Molecular Biology
  • Immunology
  • Gene Regulation

Background:

  • The nuclear receptor Rev-erbβ is a critical transcriptional factor.
  • Functional studies of Rev-erbβ have been hindered by the absence of specific antibodies.

Purpose of the Study:

  • To generate and characterize monoclonal antibodies (MAbs) against human Rev-erbβ.
  • To develop tools for investigating the biological roles of Rev-erbβ.

Main Methods:

  • Immunization of mice with purified recombinant human Rev-erbβ-6His fusion protein.
  • Generation of hybridoma cell lines secreting anti-Rev-erbβ MAbs.
  • Western blotting, immunofluorescence, and immunoprecipitation assays to assess antibody reactivity and specificity.

Main Results:

  • Five hybridoma cell lines producing anti-Rev-erbβ MAbs were successfully generated.
  • All five MAbs demonstrated strong immunoreactivity against recombinant Rev-erbβ.
  • One MAb, 37H8, exhibited the ability to immunoprecipitate endogenous Rev-erbβ.
  • Antibody cross-reactivity with Rev-erbα was observed for antibodies specific to shared C and E domains.

Conclusions:

  • The developed MAbs are valuable tools for studying Rev-erbβ.
  • The MAb 37H8 is particularly useful for detecting endogenous Rev-erbβ.
  • These antibodies will facilitate further research into Rev-erbβ's functions in biological systems.